On behalf of the Board of Directors of Exosomics and Lonza Team I would like to congratulate Dr. Chiesi and his dynamic and innovative team on this notable accomplishment.

google.it/amp/s/bioinfor… Exosomes getting a lot of attention..and $$$

Exosomics latest product #SeleCTEV™ DNA Enrichment Kit is now CE-IVD marked. See brochure exosomics.it/wp-content/upl…

Dear Network, Exosomics is in San Francisco for the J.P. Morgan Healthcare Conference. If you develop solutions for liquid biopsy or you are an investor and want to learn more on how we extract tumour-derived DNA and RNA from blood, please contact us! Exosomics #JPM19

Dear Network, Davide Zocco and I will be in the Bay Area from Jan 21st to 24th to meet with partners and investors. Send us a msg if you want to meet us and learn more about our exosome-based nex-gen liquid biopsy solutions!! #exosomes #liquidbiopsy #pre…lnkd.in/dHU3UMU

3hrs wait at us customs in SFO Due to #shutdown 2 officers 20 ppl governing the line

A new #RealWorld study of over 1700 patients analyzed plasma ctDNA fraction as a prognostic biomarker across four advanced cancers. Learn more: bit.ly/3VaiyOT

Next week at Hanson Wade's Liquid Biopsy Surveillance & Early Detection Summit, we’re excited to join industry experts to discuss the latest innovations and insights in #LiquidBiopsy. Learn more: bit.ly/3h5WCoH

Five things you can do today to improve your focus: hbr.org/2017/10/in-a-d…

Another report showing ~30% failure rate of RNAseq in NSCLC. Highlights the role of well designed hybrid capture DNAseq for reliable detection of diverse fusions and partners across tissue and ctDNA. aacrjournals.org/clincancerres/…

Thoughtful quotes from my colleague Hanna Tukachinsky in this GenomeWeb piece on 🧬Tumor Fraction. We need a world where both pos AND neg 🩸LBx have clear actionability 👉 TF is key to this. See Hatim Husain JCO Precision Oncology article for more details! genomeweb.com/cancer/foundat…

Webinar on Liquid Biopsy. #foundationmedicine #roche bit.ly/3dX35xF

In principle, RNA #NGS analysis should be better at finding fusions in #NSCLC patients. In practice, it is not, with a failure rate of 35%. #foundationmedicine DNA-based assays are a reliable option. mdpi.com/2673-5261/3/4/…

Less is more also when it comes to ppl 'it’s about surrounding yourself with a carefully curated group of people who you admire and respect and with whom you share common beliefs and values' #HBR hbr.org/2018/03/why-yo…

It seems that NSAIDs improve #NSCLC patients survival pubmed.ncbi.nlm.nih.gov/35832288/ #Cancer

There are hundreds of cognitive biases, but most of them stem from a failure to recognize that our beliefs are subject to biases. Defending our views stalls learning. Questioning them stimulates growth. The only belief worth cherishing is the belief that you might be wrong.

Noise is a secret destroyer of productivity. It is secret because it impacts cognition, not effort, so we don’t notice, but a 10db noise increase (from a dishwasher to a vacuum) lowers productivity by 5%. Noise is also greater in poorer neighborhoods... joshuatdean.com/wp-content/upl…

FTD and ALS share overlapping genetics and pathologies. Clayton et al. summarise recent evidence suggesting that presynaptic dysfunction is an early and common event in both diseases, and could represent a target for future disease-modifying therapies. tinyurl.com/whj2t9w8

Probably the biggest bias of all

This week's nature editorial The missed opportunities to save lives with genomic data, such as mutations in BRCA1 and 2 nature.com/articles/d4158…